Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis for Gastric Variceal Obliteration
NCT04140578Phase 4Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ertapenem in sepsis and bacterial infection (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Prevention of sepsis at 3 years. Started Jan 2017; status: recruiting.
02
Drugs
ertapenem
03
Conditions
sepsisbacterial infection
Beyond the preview
Go deeper on NCT04140578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140578.